Status:
COMPLETED
The Analgesic Effect of Pericapsular Nerve Group Block With Lateral Femoral Cutaneous Nerve Block and Pericapsular Nerve Group Block With Supra-inguinal Fascia Iliaca Block in Hip Hemiarthroplasty
Lead Sponsor:
Ain Shams University
Conditions:
Pericapsular Nerve Group Block
Lateral Femoral Cutaneous Nerve Block
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of this study is to investigate the efficiency of preoperative and post-operative analgesia by pericapsular nerve group block (PENG) block with supra-inguinal fascia iliaca block (SIFIC) block...
Detailed Description
The established practice to decrease pain using opioids in hip fracture surgery may result in compromised outcomes in the frail and elderly population with nausea-vomiting, constipation, delirium and ...
Eligibility Criteria
Inclusion
- Age 40-80 years.
- Sex: Both sexes.
- American Society of Anaesthesiologists (ASA) Physical Status Class I, II, and III.
- Scheduled for hip hemiarthroplasty under general anesthesia.
Exclusion
- Declining to give a written informed consent.
- History of allergy to the medications used in the study.
- Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
- Psychiatric disorders or narcotic abusers.
- Significant cognitive dysfunction.
- American Society of Anesthesiologists (ASA) Physical Status Class IV.
- Renal insufficiency (to avoid local anesthetic or nalbuphine metabolites adverse effect)
- Opioid abuser patients
- Pregnancy.
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06577103
Start Date
January 2 2024
End Date
December 1 2024
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Cairo Governorate, Egypt, 11591